Jain Global’s Cabaletta Bio CABA Stock Holding History

Jain Global’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56,160	Closed	-$85.4K	–	1066
2025 Q2	$85.4K	Buy	+56,160	New	+$87.6K	﹤0.01%	1049

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Jain Global's CABA Position: Q3 2025 in Review

Jain Global sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 56,160 shares — an estimated $85.4K sold.

Jain Global first reported a position in CABA in Q2 2025 and held it in 1 quarter. The position peaked at $85.4K in Q2 2025. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

Jain Global reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
Jain Global sold 56,160 Cabaletta Bio shares in Q3 2025, an estimated $85.4K.
Jain Global first reported a position in Cabaletta Bio in Q2 2025 and held it in 1 quarter.
Jain Global's Cabaletta Bio position peaked at $85.4K in Q2 2025.
75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.